{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:11:27Z","timestamp":1793146287489,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003702"],"award-info":[{"award-number":["82003702"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31571195"],"award-info":[{"award-number":["31571195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02700-x","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:23:21Z","timestamp":1783146201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-transferrin-bound iron uptake by cardiomyocytes"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-2628","authenticated-orcid":false,"given":"Qian","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-0455","authenticated-orcid":false,"given":"Zhong-Ming","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5827-4541","authenticated-orcid":false,"given":"Christopher","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"2700_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0167-4889(95)00098-X","volume":"1269","author":"ZM Qian","year":"1995","unstructured":"Qian ZM, Tang PL (1995) Mechanisms of iron uptake by mammalian cells. Biochim Biophys Acta 1269:205\u2013214 DOI 10.1016\/0167\u20134889(95)00098-x","journal-title":"Biochim Biophys Acta"},{"key":"2700_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0167-4889(95)00175-1","volume":"1310","author":"ZM Qian","year":"1996","unstructured":"Qian ZM, Tang PL, Morgan EH (1996) Effect of lipid peroxidation on transferrin-free iron uptake by rabbit reticulocytes. Biochim Biophys Acta 1310:293\u2013302. https:\/\/doi.org\/10.1016\/0167-4889(95)00175-1","journal-title":"Biochim Biophys Acta"},{"key":"2700_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0079-6107(","volume":"67","author":"ZM Qian","year":"1997","unstructured":"Qian ZM, Tang PL, Wang Q (1997) Iron crosses the endosomal membrane by a carrier-mediated process. Prog Biophys Mol Biol 67:1\u201315. https:\/\/doi.org\/10.1016\/s0079-6107(97)00009\u2009\u2013\u20096","journal-title":"Prog Biophys Mol Biol"},{"key":"2700_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/ndt\/gfae095","volume":"39","author":"L Del Vecchio","year":"2024","unstructured":"Del Vecchio L, Girelli D, Vinchi F, Cozzolino M, Elliott S, Mark PB, Valenti L, Qian C, Guo Q, Qian ZM et al (2024) Iron biology. Nephrol Dial Transpl 39:1404\u20131415. https:\/\/doi.org\/10.1093\/ndt\/gfae095","journal-title":"Nephrol Dial Transpl"},{"key":"2700_CR5","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1002\/j.1460-2075.1995.tb00091.x","volume":"14","author":"ML Kennard","year":"1995","unstructured":"Kennard ML, Richardson DR, Gabathuler R, Ponka P, Jefferies WA (1995) A novel iron uptake mechanism mediated by GPI-anchored human p97. Embo J 14:4178\u20134186. https:\/\/doi.org\/10.1002\/j.1460-2075.1995.tb00091.x","journal-title":"Embo J"},{"key":"2700_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/0006-2952(90)90492-4","volume":"40","author":"ZM Qian","year":"1990","unstructured":"Qian ZM, Morgan EH (1990) Effect of lead on the transport of transferrin-free and transferrin-bound iron into rabbit reticulocytes. Biochem Pharmacol 40:1049\u20131054. https:\/\/doi.org\/10.1016\/0006-2952(90)90492-4","journal-title":"Biochem Pharmacol"},{"key":"2700_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/0304-4165(91)90215-3","volume":"1073","author":"ZM Qian","year":"1991","unstructured":"Qian ZM, Morgan EH (1991) Effect of metabolic inhibitors on uptake of non-transferrin-bound iron by reticulocytes. Biochim Biophys Acta 1073:456\u2013462. https:\/\/doi.org\/10.1016\/0304-4165(91)90215-3","journal-title":"Biochim Biophys Acta"},{"key":"2700_CR8","first-page":"296","volume":"153","author":"LH Smith Jr","year":"1990","unstructured":"Smith LH Jr (1990) Overview of hemochromatosis. West J Med 153:296\u2013308","journal-title":"West J Med"},{"key":"2700_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","volume":"84","author":"GY Oudit","year":"2006","unstructured":"Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH (2006) Role of L-type Ca2\u2009+\u2009channels in iron transport and iron-overload cardiomyopathy. J Mol Med (Berl) 84:349\u2013364. https:\/\/doi.org\/10.1007\/s00109-005-0029-x","journal-title":"J Mol Med (Berl)"},{"key":"2700_CR10","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1016\/S0021-9258(18)49946-2","volume":"266","author":"J Kaplan","year":"1991","unstructured":"Kaplan J, Jordan I, Sturrock A (1991) Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 266:2997\u20133004","journal-title":"J Biol Chem"},{"key":"2700_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2015.07.019","volume":"88","author":"V Berdoukas","year":"2015","unstructured":"Berdoukas V, Coates TD, Cabantchik ZI (2015) Iron and oxidative stress in cardiomyopathy in thalassemia. Free Radic Biol Med 88:3\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.07.019","journal-title":"Free Radic Biol Med"},{"key":"2700_CR12","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1016\/S0021-9258(18)83758-9","volume":"264","author":"M Grootveld","year":"1989","unstructured":"Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ (1989) Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 264:4417\u20134422","journal-title":"J Biol Chem"},{"key":"2700_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0165-0173(98)00012-5","volume":"27","author":"ZM Qian","year":"1998","unstructured":"Qian ZM, Wang Q (1998) Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Rev 27:257\u2013267 DOI Doi 10.1016\/S0165-0173(98)00012\u2009\u2013\u20095","journal-title":"Brain Res Rev"},{"key":"2700_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00775-007-0297-8","volume":"13","author":"RW Evans","year":"2008","unstructured":"Evans RW, Rafique R, Zarea A, Rapisarda C, Cammack R, Evans PJ, Porter JB, Hider RC (2008) Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera. J Biol Inorg Chem 13:57\u201374. https:\/\/doi.org\/10.1007\/s00775-007-0297-8","journal-title":"J Biol Inorg Chem"},{"key":"2700_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1749-6632.2010.05573.x","volume":"1202","author":"RC Hider","year":"2010","unstructured":"Hider RC, Silva AM, Podinovskaia M, Ma Y (2010) Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron. Ann N Y Acad Sci 1202:94\u201399. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05573.x","journal-title":"Ann N Y Acad Sci"},{"key":"2700_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","volume":"1820","author":"P Brissot","year":"2012","unstructured":"Brissot P, Ropert M, Le Lan C, Loreal O (2012) Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 1820:403\u2013410. https:\/\/doi.org\/10.1016\/j.bbagen.2011.07.014","journal-title":"Biochim Biophys Acta"},{"key":"2700_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/15353702221076397","volume":"247","author":"S Kumfu","year":"2022","unstructured":"Kumfu S, Chattipakorn SC, Chattipakorn N (2022) Iron overload cardiomyopathy: Using the latest evidence to inform future applications. Exp Biol Med (Maywood) 247:574\u2013583. https:\/\/doi.org\/10.1177\/15353702221076397","journal-title":"Exp Biol Med (Maywood)"},{"key":"2700_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJM199409013310902","volume":"331","author":"GM Brittenham","year":"1994","unstructured":"Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331:567\u2013573. https:\/\/doi.org\/10.1056\/NEJM199409013310902","journal-title":"N Engl J Med"},{"key":"2700_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa073286","volume":"358","author":"KJ Allen","year":"2008","unstructured":"Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD et al (2008) Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 358:221\u2013230. https:\/\/doi.org\/10.1056\/NEJMoa073286","journal-title":"N Engl J Med"},{"key":"2700_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","volume":"128","author":"DJ Pennell","year":"2013","unstructured":"Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A et al (2013) Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation 128:281\u2013308. https:\/\/doi.org\/10.1161\/CIR.0b013e31829b2be6","journal-title":"Circulation"},{"key":"2700_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cjca.2015.10.012","volume":"32","author":"J Khamseekaew","year":"2016","unstructured":"Khamseekaew J, Kumfu S, Chattipakorn SC, Chattipakorn N (2016) Effects of Iron Overload on Cardiac Calcium Regulation: Translational Insights Into Mechanisms and Management of a Global Epidemic. Can J Cardiol 32:1009\u20131016. https:\/\/doi.org\/10.1016\/j.cjca.2015.10.012","journal-title":"Can J Cardiol"},{"key":"2700_CR22","doi-asserted-by":"publisher","first-page":"21613","DOI":"10.1002\/jcp.28820","volume":"234","author":"A Paterek","year":"2019","unstructured":"Paterek A, Mackiewicz U, Maczewski M (2019) Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities. J Cell Physiol 234:21613\u201321629. https:\/\/doi.org\/10.1002\/jcp.28820","journal-title":"J Cell Physiol"},{"key":"2700_CR23","doi-asserted-by":"publisher","first-page":"107886","DOI":"10.1016\/j.celrep.2020.107886","volume":"32","author":"JW Rhee","year":"2020","unstructured":"Rhee JW, Yi H, Thomas D, Lam CK, Belbachir N, Tian L, Qin X, Malisa J, Lau E, Paik DT et al (2020) Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cell Rep 32:107886. https:\/\/doi.org\/10.1016\/j.celrep.2020.107886","journal-title":"Cell Rep"},{"key":"2700_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bbadis.2007.02.006","volume":"1772","author":"ZM Qian","year":"2007","unstructured":"Qian ZM, Chang YZ, Leung G, Du JR, Zhu L, Wang Q, Niu L, Xu YJ, Yang L, Ho KP et al (2007) Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart. Biochim Biophys Acta 1772:527\u2013532. https:\/\/doi.org\/10.1016\/j.bbadis.2007.02.006","journal-title":"Biochim Biophys Acta"},{"key":"2700_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacbts.2019.08.009","volume":"5","author":"K Ghafourian","year":"2020","unstructured":"Ghafourian K, Shapiro JS, Goodman L, Ardehali H (2020) Iron and Heart Failure: Diagnosis, Therapies, and Future Directions. JACC Basic Transl Sci 5:300\u2013313. https:\/\/doi.org\/10.1016\/j.jacbts.2019.08.009","journal-title":"JACC Basic Transl Sci"},{"key":"2700_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/CIRCRESAHA.122.321667","volume":"132","author":"KT Sawicki","year":"2023","unstructured":"Sawicki KT, De Jesus A, Ardehali H (2023) Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets. Circ Res 132:379\u2013396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321667","journal-title":"Circ Res"},{"key":"2700_CR27","first-page":"147","volume":"106","author":"G Link","year":"1985","unstructured":"Link G, Pinson A, Hershko C (1985) Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med 106:147\u2013153","journal-title":"J Lab Clin Med"},{"key":"2700_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0300-483x(96)03566-4","volume":"117","author":"JG Parkes","year":"1997","unstructured":"Parkes JG, Olivieri NF, Templeton DM (1997) Characterization of Fe2\u2009+\u2009and Fe3\u2009+\u2009transport by iron-loaded cardiac myocytes. Toxicology 117:141\u2013151. https:\/\/doi.org\/10.1016\/s0300-483x(96)03566-4","journal-title":"Toxicology"},{"key":"2700_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4330\/wjc.v3.i7.215","volume":"3","author":"N Chattipakorn","year":"2011","unstructured":"Chattipakorn N, Kumfu S, Fucharoen S, Chattipakorn S (2011) Calcium channels and iron uptake into the heart. World J Cardiol 3:215\u2013218. https:\/\/doi.org\/10.4330\/wjc.v3.i7.215","journal-title":"World J Cardiol"},{"key":"2700_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1600-0609.2012.01782.x","volume":"88","author":"SK Das","year":"2012","unstructured":"Das SK, Oudit GY (2012) Voltage-gated Ca channels as key mediators of iron-transport and iron-overload cardiomyopathy: L-type vs. T-type Ca channels. Eur J Haematol 88:476\u2013477. https:\/\/doi.org\/10.1111\/j.1600-0609.2012.01782.x","journal-title":"Eur J Haematol"},{"key":"2700_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2018.10.413","volume":"133","author":"MD Knutson","year":"2019","unstructured":"Knutson MD (2019) Non-transferrin-bound iron transporters. Free Radical Bio Med 133:101\u2013111. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.413","journal-title":"Free Radical Bio Med"},{"key":"2700_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2018.01.015","volume":"822","author":"S Kumfu","year":"2018","unstructured":"Kumfu S, Khamseekaew J, Palee S, Srichairatanakool S, Fucharoen S, Chattipakorn SC, Chattipakorn N (2018) Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice. Eur J Pharmacol 822:43\u201350. https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.015","journal-title":"Eur J Pharmacol"},{"key":"2700_CR33","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/s0165-6147(00)01797-1","volume":"22","author":"JN Muth","year":"2001","unstructured":"Muth JN, Varadi G, Schwartz A (2001) Use of transgenic mice to study voltage-dependent Ca2\u2009+\u2009channels. Trends Pharmacol Sci 22:526\u2013532. https:\/\/doi.org\/10.1016\/s0165-6147(00)01797-1","journal-title":"Trends Pharmacol Sci"},{"key":"2700_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1536\/ihj.50.829","volume":"50","author":"K Sugishita","year":"2009","unstructured":"Sugishita K, Asakawa M, Usui S, Takahashi T (2009) A case of iron overload cardiomyopathy: beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction. Int Heart J 50:829\u2013838. https:\/\/doi.org\/10.1536\/ihj.50.829","journal-title":"Int Heart J"},{"key":"2700_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1042\/Bst0340903","volume":"34","author":"J Striessnig","year":"2006","unstructured":"Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen N, Busquet P, Pelster G, Singewald N (2006) Role of voltage-gated L-type Ca channel isoforms for brain function. Biochem Soc T 34:903\u2013909. https:\/\/doi.org\/10.1042\/Bst0340903","journal-title":"Biochem Soc T"},{"key":"2700_CR36","doi-asserted-by":"publisher","first-page":"e202313531","DOI":"10.1085\/jgp.202313531","volume":"157","author":"WB Limpitikul","year":"2025","unstructured":"Limpitikul WB, Dick IE (2025) Inactivation of Ca1 and Ca2 channels. J GenPhysiol 157(2):e202313531. https:\/\/doi.org\/10.1085\/jgp.202313531","journal-title":"J GenPhysiol"},{"key":"2700_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1085\/jgp.201611663","volume":"148","author":"BE Flucher","year":"2016","unstructured":"Flucher BE (2016) Specific contributions of the four voltage-sensing domains in L-type calcium channels to gating and modulation. J Gen Physiol 148:91\u201395. https:\/\/doi.org\/10.1085\/jgp.201611663","journal-title":"J Gen Physiol"},{"key":"2700_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","volume":"16","author":"WA Catterall","year":"2000","unstructured":"Catterall WA (2000) Structure and regulation of voltage-gated Ca channels. Annu Rev Cell Dev Bi 16:521\u2013555. https:\/\/doi.org\/10.1146\/annurev.cellbio.16.1.521","journal-title":"Annu Rev Cell Dev Bi"},{"key":"2700_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411\u2013425. https:\/\/doi.org\/10.1124\/pr.57.4.5","journal-title":"Pharmacol Rev"},{"key":"2700_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/03630269.2014.987869","volume":"39","author":"K Wijarnpreecha","year":"2015","unstructured":"Wijarnpreecha K, Kumfu S, Chattipakorn SC, Chattipakorn N (2015) Cardiomyopathy Associated with Iron Overload: How Does Iron Enter Myocytes and What are the Implications for Pharmacological Therapy? Hemoglobin 39:9\u201317. https:\/\/doi.org\/10.3109\/03630269.2014.987869","journal-title":"Hemoglobin"},{"key":"2700_CR41","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cjca.2015.11.017","volume":"32","author":"GY Oudit","year":"2016","unstructured":"Oudit GY, Backx PH (2016) Amlodipine Therapy for Iron-Overload Cardiomyopathy: The Enduring Value of Translational Research. Can J Cardiol 32:938\u2013940. https:\/\/doi.org\/10.1016\/j.cjca.2015.11.017","journal-title":"Can J Cardiol"},{"key":"2700_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/FJC.0000000000000525","volume":"70","author":"S Kumfu","year":"2017","unstructured":"Kumfu S, Chattipakorn SC, Chattipakorn N (2017) T-type and L-type Calcium Channel Blockers for the Treatment of Cardiac Iron Overload: An Update. J Cardiovasc Pharmacol 70:277\u2013283. https:\/\/doi.org\/10.1097\/FJC.0000000000000525","journal-title":"J Cardiovasc Pharmacol"},{"key":"2700_CR43","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1002\/jcp.30219","volume":"236","author":"S Kumfu","year":"2021","unstructured":"Kumfu S, Siri-Angkul N, Chattipakorn SC, Chattipakorn N (2021) Silencing of lipocalin-2 improves cardiomyocyte viability under iron overload conditions via decreasing mitochondrial dysfunction and apoptosis. J Cell Physiol 236:5108\u20135120. https:\/\/doi.org\/10.1002\/jcp.30219","journal-title":"J Cell Physiol"},{"key":"2700_CR44","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/01.res.84.11.1302","volume":"84","author":"RG Tsushima","year":"1999","unstructured":"Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH (1999) Modulation of iron uptake in heart by L-type Ca2\u2009+\u2009channel modifiers: possible implications in iron overload. Circ Res 84:1302\u20131309. https:\/\/doi.org\/10.1161\/01.res.84.11.1302","journal-title":"Circ Res"},{"key":"2700_CR45","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm920","volume":"9","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP et al (2003) L-type Ca channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9:1187\u20131194. https:\/\/doi.org\/10.1038\/nm920","journal-title":"Nat Med"},{"key":"2700_CR46","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1161\/01.Cir.0000124229.40424.80","volume":"109","author":"GY Oudit","year":"2004","unstructured":"Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ, Backx PH (2004) Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 109:1877\u20131885. https:\/\/doi.org\/10.1161\/01.Cir.0000124229.40424.80","journal-title":"Circulation"},{"key":"2700_CR47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","volume":"16","author":"CJ Murphy","year":"2010","unstructured":"Murphy CJ, Oudit GY (2010) Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment. J Card Fail 16:888\u2013900. https:\/\/doi.org\/10.1016\/j.cardfail.2010.05.009","journal-title":"J Card Fail"},{"key":"2700_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/109980040200300404","volume":"3","author":"S Crowe","year":"2002","unstructured":"Crowe S, Bartfay WJ (2002) Amlodipine decreases iron uptake and oxygen free radical production in the heart of chronically iron overloaded mice. Biol Res Nurs 3:189\u2013197. https:\/\/doi.org\/10.1177\/109980040200300404","journal-title":"Biol Res Nurs"},{"key":"2700_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00210-013-0863-2","volume":"386","author":"HL Shan","year":"2013","unstructured":"Shan HL, Wang Y, Wu JW, Hang PZ, Li X, Sun LH, Qi JC, Mao YY, Sun ZD, Du ZM (2013) Verapamil reverses cardiac iron overload in streptozocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 386:645\u2013650. https:\/\/doi.org\/10.1007\/s00210-013-0863-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2700_CR50","first-page":"180","volume":"12","author":"HR Nasri","year":"2016","unstructured":"Nasri HR, Shahouzehi B, Masoumi-Ardakani Y, Iranpour M (2016) Effects of digoxin on cardiac iron content in rat model of iron overload. ARYA Atheroscler 12:180\u2013184","journal-title":"ARYA Atheroscler"},{"key":"2700_CR51","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.amjmed.2013.05.002","volume":"126","author":"JL Fernandes","year":"2013","unstructured":"Fernandes JL, Sampaio EF, Fertrin K, Coelho OR, Loggetto S, Piga A, Verissimo M, Saad ST (2013) Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial. Am J Med 126:834\u2013837. https:\/\/doi.org\/10.1016\/j.amjmed.2013.05.002","journal-title":"Am J Med"},{"key":"2700_CR52","doi-asserted-by":"publisher","first-page":"e112915","DOI":"10.1371\/journal.pone.0112915","volume":"9","author":"MP Chen","year":"2014","unstructured":"Chen MP, Cabantchik ZI, Chan S, Chan GC, Cheung YF (2014) Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade. PLoS ONE 9:e112915. https:\/\/doi.org\/10.1371\/journal.pone.0112915","journal-title":"PLoS ONE"},{"key":"2700_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1600-0609.2010.01549.x","volume":"86","author":"S Kumfu","year":"2011","unstructured":"Kumfu S, Chattipakorn S, Srichairatanakool S, Settakorn J, Fucharoen S, Chattipakorn N (2011) T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice. Eur J Haematol 86:156\u2013166. https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01549.x","journal-title":"Eur J Haematol"},{"key":"2700_CR54","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1124\/mol.112.080184","volume":"82","author":"KV Lopin","year":"2012","unstructured":"Lopin KV, Gray IP, Obejero-Paz CA, Thevenod F, Jones SW (2012) Fe(2)(+) block and permeation of CaV3.1 (alpha1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe(2)(+) influx. Mol Pharmacol 82:1194\u20131204. https:\/\/doi.org\/10.1124\/mol.112.080184","journal-title":"Mol Pharmacol"},{"key":"2700_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1113\/EP085517","volume":"101","author":"S Kumfu","year":"2016","unstructured":"Kumfu S, Chattipakorn SC, Fucharoen S, Chattipakorn N (2016) Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice. Exp Physiol 101:521\u2013539. https:\/\/doi.org\/10.1113\/EP085517","journal-title":"Exp Physiol"},{"key":"2700_CR56","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/01.res.73.4.777","volume":"73","author":"HB Nuss","year":"1993","unstructured":"Nuss HB, Houser SR (1993) T-type Ca2\u2009+\u2009current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73:777\u2013782. https:\/\/doi.org\/10.1161\/01.res.73.4.777","journal-title":"Circ Res"},{"key":"2700_CR57","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1006\/jmcc.1999.0998","volume":"31","author":"ML Martinez","year":"1999","unstructured":"Martinez ML, Heredia MP, Delgado C (1999) Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 31:1617\u20131625. https:\/\/doi.org\/10.1006\/jmcc.1999.0998","journal-title":"J Mol Cell Cardiol"},{"key":"2700_CR58","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/s0008-6363(","volume":"46","author":"B Huang","year":"2000","unstructured":"Huang B, Qin D, Deng L, Boutjdir M, N E-S (2000) Reexpression of T-type Ca2\u2009+\u2009channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46:442\u2013449. https:\/\/doi.org\/10.1016\/s0008-6363(00)00017\u2009\u2013\u20091","journal-title":"Cardiovasc Res"},{"key":"2700_CR59","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng0897-383","volume":"16","author":"MD Fleming","year":"1997","unstructured":"Fleming MD, Trenor CC, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16:383\u2013386. https:\/\/doi.org\/10.1038\/ng0897-383","journal-title":"Nat Genet"},{"key":"2700_CR60","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/41343","volume":"388","author":"H Gunshin","year":"1997","unstructured":"Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482\u2013488. https:\/\/doi.org\/10.1038\/41343","journal-title":"Nature"},{"key":"2700_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/bcmd.1998.0186","volume":"24","author":"PL Lee","year":"1998","unstructured":"Lee PL, Gelbart T, West C, Halloran C, Beutler E (1998) The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis 24:199\u2013215. https:\/\/doi.org\/10.1006\/bcmd.1998.0186","journal-title":"Blood Cells Mol Dis"},{"key":"2700_CR62","doi-asserted-by":"publisher","first-page":"12345","DOI":"10.1073\/pnas.192423399","volume":"99","author":"N Hubert","year":"2002","unstructured":"Hubert N, Hentze MW (2002) Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A 99:12345\u201312350. https:\/\/doi.org\/10.1073\/pnas.192423399","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2700_CR63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jcp.10284","volume":"196","author":"Y Ke","year":"2003","unstructured":"Ke Y, Chen YY, Chang YZ, Duan XL, Ho KP, Jiang DH, Wang K, Qian ZM (2003) Post-transcriptional expression of DMT1 in the heart of rat. J Cell Physiol 196:124\u2013130. https:\/\/doi.org\/10.1002\/jcp.10284","journal-title":"J Cell Physiol"},{"key":"2700_CR64","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3324\/haematol.2012.072314","volume":"98","author":"H Nam","year":"2013","unstructured":"Nam H, Wang CY, Zhang L, Zhang W, Hojyo S, Fukada T, Knutson MD (2013) ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Haematologica 98:1049\u20131057. https:\/\/doi.org\/10.3324\/haematol.2012.072314","journal-title":"Haematologica"},{"issue":"5","key":"2700_CR65","doi-asserted-by":"publisher","first-page":"L987","DOI":"10.1152\/ajplung.00253.2001","volume":"282","author":"X Wang","year":"2002","unstructured":"Wang X, Ghio AJ, Yang F, Dolan KG, Garrick MD, Piantadosi CA (2002) Iron uptake and Nramp2\/DMT1\/DCT1 in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 282(5):L987\u2013L995. https:\/\/doi.org\/10.1152\/ajplung.00253.2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"2700_CR66","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/s0006-2952(03)00181-3","volume":"65","author":"B Scheiber-Mojdehkar","year":"2003","unstructured":"Scheiber-Mojdehkar B, Sturm B, Plank L, Kryzer I, Goldenberg H (2003) Influence of parenteral iron preparations on non-transferrin bound iron uptake, the iron regulatory protein and the expression of ferritin and the divalent metal transporter DMT-1 in HepG2 human hepatoma cells. Biochem Pharmacol 65(12):1973\u20131978. https:\/\/doi.org\/10.1016\/s0006-2952(03)00181-3","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2700_CR67","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.hepres.2006.03.011","volume":"35","author":"M Shindo","year":"2006","unstructured":"Shindo M, Torimoto Y, Saito H, Motomura W, Ikuta K, Sato K, Fujimoto Y, Kohgo Y (2006) Functional role of\u2002DMT1\u2002in transferrin-independent\u2002iron\u2002uptake\u2002by\u2002human\u2002hepatocyte and hepatocellular carcinoma cell, HLF. Hepatol Res 35(3):152\u2013162. https:\/\/doi.org\/10.1016\/j.hepres.2006.03.011","journal-title":"Hepatol Res"},{"key":"2700_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1099800403261350","volume":"6","author":"MT Davis","year":"2004","unstructured":"Davis MT, Bartfay WJ (2004) Ebselen decreases oxygen free radical production and iron concentrations in the hearts of chronically iron-overloaded mice. Biol Res Nurs 6:37\u201345. https:\/\/doi.org\/10.1177\/1099800403261350","journal-title":"Biol Res Nurs"},{"key":"2700_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1600-0609.2012.01779.x","volume":"88","author":"S Kumfu","year":"2012","unstructured":"Kumfu S, Chattipakorn S, Chinda K, Fucharoen S, Chattipakorn N (2012) T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol 88:535\u2013548. https:\/\/doi.org\/10.1111\/j.1600-0609.2012.01779.x","journal-title":"Eur J Haematol"},{"key":"2700_CR70","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/fcp.12793","volume":"36","author":"LR Jiang","year":"2022","unstructured":"Jiang LR, Shen MQ, Bao YX, Qian ZM (2022) Verapamil downregulates iron uptake and upregulates divalent metal transporter 1 expression in H9C2 cardiomyocytes. Fundam Clin Pharmacol 36:985\u2013991. https:\/\/doi.org\/10.1111\/fcp.12793","journal-title":"Fundam Clin Pharmacol"},{"key":"2700_CR71","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm1542","volume":"13","author":"S Ludwiczek","year":"2007","unstructured":"Ludwiczek S, Theurl I, Muckenthaler MU, Jakab M, Mair SM, Theurl M, Kiss J, Paulmichl M, Hentze MW, Ritter M et al (2007) Ca2\u2009+\u2009channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med 13:448\u2013454. https:\/\/doi.org\/10.1038\/nm1542","journal-title":"Nat Med"},{"key":"2700_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fphar.2017.00060","volume":"8","author":"SS Yu","year":"2017","unstructured":"Yu SS, Jiang LR, Ling Y, Qian ZM, Zhou YF, Li J, Ke Y (2017) Nifedipine Increases Iron Content in WKPT-0293 Cl.2 Cells via Up-Regulating Iron Influx Proteins. Front Pharmacol 8:60. https:\/\/doi.org\/10.3389\/fphar.2017.00060","journal-title":"Front Pharmacol"},{"issue":"20","key":"2700_CR73","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1182\/blood-2010-03-274738","volume":"115","author":"B Mackenzie","year":"2010","unstructured":"Mackenzie B, Shawki A, Ghio AJ, Stonehuerner JD, Zhao L, Ghadersohi S, Garrick LM, Garrick MD (2010) Calcium-channel blockers do not affect iron transport mediated by divalent metal-ion transporter-1. Blood 115(20):4148\u20134149. https:\/\/doi.org\/10.1182\/blood-2010-03-274738","journal-title":"Blood"},{"key":"2700_CR74","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/jmcc.1999.1068","volume":"32","author":"JG Parkes","year":"2000","unstructured":"Parkes JG, Liu Y, Sirna JB, Templeton DM (2000) Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. J Mol Cell Cardiol 32:233\u2013246. https:\/\/doi.org\/10.1006\/jmcc.1999.1068","journal-title":"J Mol Cell Cardiol"},{"key":"2700_CR75","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0022-2828(","volume":"35","author":"Y Liu","year":"2003","unstructured":"Liu Y, Parkes JG, Templeton DM (2003) Differential accumulation of non-transferrin-bound iron by cardiac myocytes and fibroblasts. J Mol Cell Cardiol 35:505\u2013514. https:\/\/doi.org\/10.1016\/s0022-2828(03)00072\u2009\u2013\u20095","journal-title":"J Mol Cell Cardiol"},{"key":"2700_CR76","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/1471-2164-8-379","volume":"8","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Hilvo M, Kytomaki L, Fleming RE, Britton RS, Bacon BR, Parkkila S (2007) Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse. BMC Genomics 8:379. https:\/\/doi.org\/10.1186\/1471-2164-8-379","journal-title":"BMC Genomics"},{"key":"2700_CR77","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41569-019-0331-x","volume":"17","author":"E Karbassi","year":"2020","unstructured":"Karbassi E, Fenix A, Marchiano S, Muraoka N, Nakamura K, Yang X, Murry CE (2020) Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol 17:341\u2013359. https:\/\/doi.org\/10.1038\/s41569-019-0331-x","journal-title":"Nat Rev Cardiol"},{"issue":"2\u20133","key":"2700_CR78","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0300-483x(96)03566-4","volume":"117","author":"JG Parkes","year":"1997","unstructured":"Parkes JG, Olivieri NF, Templeton DM (1997) Characterization of Fe2\u2009+\u2009and Fe3\u2009+\u2009transport by iron-loaded cardiac myocytes. Toxicology 117(2\u20133):141\u2013151. https:\/\/doi.org\/10.1016\/s0300-483x(96)03566-4","journal-title":"Toxicology"},{"issue":"5","key":"2700_CR79","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0022-2828(03)00072-5","volume":"35","author":"Y Liu","year":"2003","unstructured":"Liu Y, Parkes JG, Templeton DM (2003) Differential accumulation of non-transferrin-bound iron by cardiac myocytes and fibroblasts. J Mol Cell Cardiol 35(5):505\u2013514. https:\/\/doi.org\/10.1016\/s0022-2828(03)00072-5","journal-title":"J Mol Cell Cardiol"},{"key":"2700_CR80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/01480545.2012.726625","volume":"36","author":"S Kumfu","year":"2013","unstructured":"Kumfu S, Chattipakorn S, Fucharoen S, Chattipakorn N (2013) Ferric iron uptake into cardiomyocytes of beta-thalassemic mice is not through calcium channels. Drug Chem Toxicol 36:329\u2013334. https:\/\/doi.org\/10.3109\/01480545.2012.726625","journal-title":"Drug Chem Toxicol"},{"issue":"Pt 1","key":"2700_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3180001","volume":"318","author":"DR Flower","year":"1996","unstructured":"Flower DR (1996) The lipocalin protein family: structure and function. Biochem J 318(Pt 1):1\u201314. https:\/\/doi.org\/10.1042\/bj3180001","journal-title":"Biochem J"},{"key":"2700_CR82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/geno.1997.4896","volume":"45","author":"JB Cowland","year":"1997","unstructured":"Cowland JB, Borregaard N (1997) Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45:17\u201323. https:\/\/doi.org\/10.1006\/geno.1997.4896","journal-title":"Genomics"},{"key":"2700_CR83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10534-005-3251-7","volume":"19","author":"N Borregaard","year":"2006","unstructured":"Borregaard N, Cowland JB (2006) Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals 19:211\u2013215. https:\/\/doi.org\/10.1007\/s10534-005-3251-7","journal-title":"Biometals"},{"key":"2700_CR84","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917\u2013921. https:\/\/doi.org\/10.1038\/nature03104","journal-title":"Nature"},{"key":"2700_CR85","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","volume":"123","author":"LR Devireddy","year":"2005","unstructured":"Devireddy LR, Gazin C, Zhu X, Green MR (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123:1293\u20131305. https:\/\/doi.org\/10.1016\/j.cell.2005.10.027","journal-title":"Cell"},{"key":"2700_CR86","doi-asserted-by":"publisher","first-page":"1229885","DOI":"10.3389\/fimmu.2023.1229885","volume":"14","author":"SK Schroder","year":"2023","unstructured":"Schroder SK, Gasterich N, Weiskirchen S, Weiskirchen R (2023) Lipocalin 2 receptors: facts, fictions, and myths. Front Immunol 14:1229885. https:\/\/doi.org\/10.3389\/fimmu.2023.1229885","journal-title":"Front Immunol"},{"key":"2700_CR87","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1253\/circj.CJ-09-0485","volume":"74","author":"LM Ding","year":"2010","unstructured":"Ding LM, Hanawa H, Ota Y, Hasegawa G, Hao K, Asami F, Watanabe R, Yoshida T, Toba K, Yoshida K et al (2010) Lipocalin-2\/Neutrophil Gelatinase-B Associated Lipocalin Is Strongly Induced in Hearts of Rats With Autoimmune Myocarditis and in Human Myocarditis. Circ J 74:523\u2013530. https:\/\/doi.org\/10.1253\/circj.CJ-09-0485","journal-title":"Circ J"},{"key":"2700_CR88","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.arcmed.2007.12.002","volume":"39","author":"MH Roudkenar","year":"2008","unstructured":"Roudkenar MH, Halabian R, Odi A, Roushandeh AM, Yaghmai P, Najar MR, Amirizadeh N, Shokrgozar MA (2008) Upregulation of neutrophil gelatinase-associated lipocalin, NGAL\/Lcn2, in \u03b2-thalassemia patients. Arch Med Res 39:402\u2013407. https:\/\/doi.org\/10.1016\/j.arcmed.2007.12.002","journal-title":"Arch Med Res"},{"key":"2700_CR89","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1074\/jbc.M111.275719","volume":"287","author":"G Xu","year":"2012","unstructured":"Xu G, Ahn J, Chang S, Eguchi M, Ogier A, Han S, Park Y, Shim C, Jang YS, Yang B et al (2012) Lipocalin-2 Induces Cardiomyocyte Apoptosis by Increasing Intracellular Iron Accumulation. J Biol Chem 287:4808\u20134817. https:\/\/doi.org\/10.1074\/jbc.M111.275719","journal-title":"J Biol Chem"},{"key":"2700_CR90","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1097-2765(02)00710-4","volume":"10","author":"J Yang","year":"2002","unstructured":"Yang J, Goetz D, Li JY, Wang WG, Mori K, Setlik D, Du TG, Erdjument-Bromage H, Tempst P, Strong R et al (2002) An iron delivery pathway mediated by a lipocalin. Mol Cell 10:1045\u20131056. https:\/\/doi.org\/10.1016\/S1097-2765(02)00710-4","journal-title":"Mol Cell"},{"key":"2700_CR91","doi-asserted-by":"publisher","unstructured":"Liuzzi JP, Cousins RJ (2004) Mammalian zinc transporters. Annu Rev Nutr 24:151\u2009\u2013\u200972. https:\/\/doi.org\/10.1146\/annurev.nutr.24.012003.132402","DOI":"10.1146\/annurev.nutr.24.012003.132402"},{"key":"2700_CR92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.yjmcc.2025.11.014","volume":"211","author":"L Zhao","year":"2026","unstructured":"Zhao L, Cao Y, Liu X, Yang Q, Xu Z (2026) ZIP14 upregulation leads to ferroptosis and lysosomal dysfunction through intracellular iron overload and induces myocardial ischemia\/reperfusion injury in mouse hearts. J Mol Cell Cardiol 211:78\u201391. https:\/\/doi.org\/10.1016\/j.yjmcc.2025.11.014","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2700_CR93","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0003-4975(94)00726-N","volume":"59","author":"G Drossos","year":"1995","unstructured":"Drossos G, Lazou A, Panagopoulos P, Westaby S (1995) Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann Thorac Surg 59(1):169\u2013172. https:\/\/doi.org\/10.1016\/0003-4975(94)00726-N","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"2700_CR94","first-page":"1313","volume":"46","author":"JH Kramer","year":"2000","unstructured":"Kramer JH, Lightfoot FG, Weglicki WB (2000) Cardiac tissue iron: effects on post-ischemic function and free radical production, and its possible role during preconditioning. Cell Mol Biol (Noisy-le-Grand) 46(8):1313\u20131327","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"issue":"37","key":"2700_CR95","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1073\/pnas.0606424103","volume":"103","author":"JP Liuzzi","year":"2006","unstructured":"Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ (2006) Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S A 103(37):13612\u201313617. https:\/\/doi.org\/10.1073\/pnas.0606424103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"2700_CR96","doi-asserted-by":"publisher","first-page":"21462","DOI":"10.1074\/jbc.M803150200","volume":"283","author":"J Gao","year":"2008","unstructured":"Gao J, Zhao N, Knutson MD, Enns CA (2008) The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of Zip14 in HepG2 cells. J Biol Chem 283(31):21462\u201321468. https:\/\/doi.org\/10.1074\/jbc.M803150200","journal-title":"J Biol Chem"},{"issue":"4","key":"2700_CR97","doi-asserted-by":"publisher","first-page":"C862","DOI":"10.1152\/ajpcell.00479.2010","volume":"301","author":"JJ Pinilla-Tenas","year":"2011","unstructured":"Pinilla-Tenas JJ, Sparkman BK, Shawki A, Illing AC, Mitchell CJ, Zhao N, Liuzzi JP, Cousins RJ, Knutson MD, Mackenzie B (2011) Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. Am J Physiol Cell Physiol 301(4):C862\u2013C871. https:\/\/doi.org\/10.1152\/ajpcell.00479.2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"2700_CR98","doi-asserted-by":"publisher","first-page":"C169","DOI":"10.1152\/ajpcell.00116.2016","volume":"312","author":"R Coffey","year":"2017","unstructured":"Coffey R, Knutson MD (2017) The plasma membrane metal-ion transporter ZIP14 contributes to nontransferrin-bound iron uptake by human \u03b2-cells. Am J Physiol Cell Physiol 312(2):C169\u2013C175. https:\/\/doi.org\/10.1152\/ajpcell.00116.2016","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"2700_CR99","doi-asserted-by":"publisher","first-page":"e2411380","DOI":"10.1002\/advs.202411380","volume":"12","author":"Z Deng","year":"2025","unstructured":"Deng Z, Zeng W, Gao Y, Yang Z, Luo X, Li X, Sun G, Xiong E, Huang F, Luo G, Hei Z, Yuan D (2025) Mesenchymal Stem Cells Prevent SLC39A14-Dependent Hepatocyte Ferroptosis through Exosomal miR-16-5p in Liver Graft. Adv Sci (Weinh) 12(6):e2411380. https:\/\/doi.org\/10.1002\/advs.202411380","journal-title":"Adv Sci (Weinh)"},{"key":"2700_CR100","doi-asserted-by":"publisher","unstructured":"Olivera J, Hoyjo S, Fukada T, Knutson MD (2025) SLC39A14 is required for iron loading of the anterior pituitary of mice with genetic iron overload. Biol Trace Elem Res. https:\/\/doi.org\/10.1007\/s12011-025-04879-5","DOI":"10.1007\/s12011-025-04879-5"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02700-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:23:24Z","timestamp":1783146204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02700-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02700-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}